Lineage Cell Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Lineage Cell Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Lineage Cell Therapeutics Inc Strategy Report
- Understand Lineage Cell Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Lineage Cell Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
22 Mar 2024 | Lineage Cell Therapeutics to Raise Up to USD40 Million in Public Offering of Common Stock | Equity Offering | - |
Lineage Cell Therapeutics Inc |
06 Feb 2024 | Lineage Cell Therapeutics Raises USD14 Million in Registered Direct Offering of Shares | Equity Offering |
Don M Bailey
Broadwood Partners, L.P.
|
Lineage Cell Therapeutics Inc |
22 Feb 2023 | Eterna Therapeutics Enters into Option License Agreement with Lineage Cell Therapeutics | Licensing Agreement |
Eterna Therapeutics Inc
|
Lineage Cell Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer